![]() |
|
|
|
|
The pathology reporting of breast cancer: a guide for pathologists, surgeons, radiologists and oncologistsThe guide has been updated to reflect the latest evidence and consensus opinion in relation to the handling, examination and reporting of invasive carcinoma and ductal carcinoma in situ (DCIS). Includes updated versions of synoptic reports for invasive carcinoma and DCIS. Recommendations for use of sentinel node biopsy in early (operable) breast cancerA clinical practice guideline developed by NBOCC. This document supplements guideline recommendation 9 about axillary node dissection (page 8) and information about sentinel node biopsy (page 57) contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001. Recommedations for use of taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer A clinical practice guideline developed by NBOCC. This document supplements systemic adjuvant therapy guideline recommendations 12-22 (pp 8-10), specially those about chemotherapy regimens contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.
Recommendations for use of endocrine therapy for the treatment of hormone receptor-positive advanced breast cancer A clinical practice guideline developed by NBOCC. This document supplements guideline recommendations 22, 24a and 24b about the use of endocrine therapy in National Breast Cancer Centre (NBCC) Clinical Practice Guidelines for the Management of Advanced Breast Cancer, 2nd edition, 2001 (page 9).
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
National Breast and Ovarian Cancer Centre | breasthealth | Clinical Best Practice | Ovarian Cancer |
|||